EUVIMEDEUVIMED entdecken
Open Access

Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID ‐19 Vaccines Among Adults in the Vaccine Safety Datalink

Thomas G Boyce iD, David L McClure iD, Kayla E Hanson iD, Matthew F Daley iD, Malini B DeSilva iD, Stephanie A Irving iD, Lisa A Jackson iD, Nicola P Klein iD, Bruno Lewin iD, Joshua T B Williams iD, Jonathan Duffy iD, Michael M McNeil iD und 2 weitere

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Thomas G Boyce und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Hospitalization, Severity of Illness Index. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Vaccine‐associated enhanced disease (VAED) is a theoretical concern with new vaccines, although trials of authorized vaccines against SARS‐CoV‐2 have not identified markers for VAED. The purpose of this study was to detect any signals for VAED among adults vaccinated against coronavirus disease 2019 (COVID‐19).

Methods

In this cross‐sectional study, we assessed COVID‐19 severity as a proxy for VAED among 400 adults hospitalized for COVID‐19 from March through October 2021 at eight US healthcare systems. Primary outcomes were admission to an intensive care unit (ICU) and severe illness (score ≥6 on the World Health Organization [WHO] Clinical Progression Scale). We compared the risk of outcomes among those who had completed a COVID‐19 vaccine primary series versus those who were unvaccinated. We incorporated inverse propensity weights for vaccination status in a doubly robust regression model to estimate the causal average treatment effect.

Results

The causal risk ratio in vaccinated versus unvaccinated was 0.36 (95% confidence interval [CI], 0.15–0.94) for ICU admission and 0.46 (95% CI, 0.25–0.76) for severe illness.

Conclusion

Among hospitalized patients, reduced disease severity in those vaccinated against COVID‐19 supports the absence of VAED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesHospitalizationSeverity of Illness IndexAdultAgedFemaleHumansMaleMiddle AgedCross-Sectional StudiesIntensive Care UnitsUnited StatesVaccination

Stichwörter der Autor:innen

COVID‐19 vaccinesSARS‐CoV‐2vaccine safetyvaccine‐associated enhanced disease

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
  • Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
  • HealthPartners Institute, Bloomington, Minnesota, USA.
  • Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California, USA.

ORCID-Profile: Thomas G Boyce, David L McClure, Kayla E Hanson, Matthew F Daley, Malini B DeSilva, Stephanie A Irving, Lisa A Jackson, Nicola P Klein, Bruno Lewin, Joshua T B Williams, Jonathan Duffy, Michael M McNeil, Eric S Weintraub, Edward A Belongia

Förderung

  • Intramural CDC HHS
  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Boyce, T. G., McClure, D. L., Hanson, K. E., Daley, M. F., DeSilva, M. B., Irving, S. A., Jackson, L. A., Klein, N. P., Lewin, B., Williams, J. T. B., Duffy, J., McNeil, M. M., Weintraub, E. S., & Belongia, E. A. (2024). Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID ‐19 Vaccines Among Adults in the Vaccine Safety Datalink. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5863

Vancouver

Boyce TG, McClure DL, Hanson KE, Daley MF, DeSilva MB, Irving SA, et al. Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID ‐19 Vaccines Among Adults in the Vaccine Safety Datalink. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5863

BibTeX
@article{Boyce2024,
  author = {Boyce, Thomas G and McClure, David L and Hanson, Kayla E and Daley, Matthew F and DeSilva, Malini B and Irving, Stephanie A and Jackson, Lisa A and Klein, Nicola P and Lewin, Bruno and Williams, Joshua T B and Duffy, Jonathan and McNeil, Michael M and Weintraub, Eric S and Belongia, Edward A},
  title = {Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID ‐19 Vaccines Among Adults in the Vaccine Safety Datalink},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5863}
}
Kostenlos starten →